|
MRUS
|
US |
MERUS NV |
3,874,182 |
$163M |
11.94% |
15.6%
|
- |
|
PCVX
|
US |
VAXCYTE INC |
1,625,000 |
$133M |
9.75% |
76.6%
|
- |
|
NUVL
|
US |
NUVALENT INC-A |
1,621,600 |
$127M |
9.30% |
72.5%
|
- |
|
XENE
|
US |
XENON PHARMACEUTICALS INC |
2,740,000 |
$107M |
7.87% |
1.5%
|
- |
|
ELVN
|
US |
ENLIVEN THERAPEUTICS INC |
4,205,000 |
$95M |
6.93% |
2.6%
|
- |
|
VERA
|
US |
VERA THERAPEUTICS INC |
1,958,600 |
$83M |
6.07% |
-20.9%
|
- |
|
SLNO
|
US |
SOLENO THERAPEUTICS INC |
1,525,000 |
$69M |
5.02% |
21.0%
|
- |
|
ALKS
|
US |
ALKERMES PLC |
2,300,000 |
$66M |
4.85% |
-20.7%
|
- |
|
NRIX
|
US |
NURIX THERAPEUTICS INC |
3,000,000 |
$57M |
4.14% |
81.8%
|
- |
|
COGT
|
US |
COGENT BIOSCIENCES INC |
6,881,629 |
$54M |
3.93% |
-8.7%
|
- |
|
SYRE
|
US |
SPYRE THERAPEUTICS INC |
1,988,084 |
$46M |
3.39% |
-
|
- |
|
VRDN
|
US |
VIRIDIAN THERAPEUTICS INC |
2,400,000 |
$46M |
3.37% |
-5.9%
|
- |
|
SRRK
|
US |
SCHOLAR ROCK HOLDING CORP |
950,000 |
$41M |
3.01% |
100.0%
|
- |
|
CNTA
|
US |
CENTESSA PHARMACEUTICALS-ADR |
2,218,425 |
$37M |
2.72% |
64.3%
|
- |
|
PHVS
|
US |
PHARVARIS NV |
1,911,433 |
$37M |
2.69% |
-
|
- |
|
MNMD
|
US |
MIND MEDICINE MINDMED INC |
4,308,425 |
$30M |
2.20% |
-46.1%
|
- |
|
ORKA
|
US |
ORUKA THERAPEUTICS INC |
1,419,714 |
$28M |
2.02% |
3.7%
|
- |
|
CRDF
|
US |
CARDIFF ONCOLOGY INC |
5,384,616 |
$23M |
1.71% |
100.0%
|
- |
|
IKT
|
US |
INHIBIKASE THERAPEUTICS INC |
5,925,000 |
$19M |
1.41% |
100.0%
|
- |
|
NGNE
|
US |
NEUROGENE INC |
800,000 |
$18M |
1.34% |
300.0%
|
- |